You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 科倫藥業(002422.SZ)大漲7% 在第三批國家藥品集採中入選4個品種
格隆匯 08-21 11:47
格隆匯8月21日丨科倫藥業(002422.SZ)午間大幅收漲6.92%,報25.02元,成交額放大至7.15億元,最新總市值357億元。在第三批國家組織藥品集中採購科倫藥業參與投標5個品種,其中4個品種、6個品規中選:枸櫞酸託法替布片(5mg)、氫溴酸西酞普蘭片(20mg)/氫溴酸西酞普蘭膠囊(20mg)、鹽酸達泊西汀片(30mg/60mg)、阿莫西林顆粒(0.125g)。此前“複方氨基酸(16AA-II)/葡萄糖(48%)電解質注射液”獲藥品註冊證書。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account